Amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil and what is the scope of patent protection?
Amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil
is the generic ingredient in two branded drugs marketed by Par Pharm Inc, Teva Pharms Usa, Torrent, and Cosette, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.Seven suppliers are listed for this compound.
Summary for amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 4 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 7 |
Clinical Trials: | 4 |
DailyMed Link: | amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil at DailyMed |
Recent Clinical Trials for amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Daiichi Sankyo, Inc. | Phase 3 |
Daiichi Sankyo Inc. | Phase 3 |
Daiichi Sankyo, Inc. | Phase 4 |
See all amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil clinical trials